CONNECT WITH US
Tech

Tech

A91 Partners, Xponentia Sell SEDEMAC Shares Via ₹1,456.4 Cr Bulk Deals

Inc42 - All News logo

Published on

Add as a preferred source on Google
A91 Partners, Xponentia Sell SEDEMAC Shares Via ₹1,456.4 Cr Bulk Deals

Shortly after the IPO lock-in expiry, SEDEMAC’s institutional investors A91 Partners, Xponentia, NJRN Family Trust and Mace Pvt Ltd have cumulatively offloaded shares worth ₹1,456.38 Cr via multiple bulk deals today. 

As per NSE data, A91 Partners, via holding entity A91 Emerging Fund II LLP, sold 16.10 Lakh shares of SEDEMAC at an average price of ₹3,010 apiece, netting ₹484.9 Cr. Xponentia sold 16.85 Lakh shares across three bulk deals to rake in ₹507.4 Cr.

Meanwhile, Mace Private Limited sold 7.28 Lakh shares worth ₹219 Cr, NJRN Family Trust offloaded 4.5 Lakh shares worth ₹135 Cr. Meanwhile, HDFC Life Insurance sold 3.63 Lakh but picked up 4.02 Lakh shares.

The shares that flooded the market were picked up by Government of Singapore (10.23 Lakh shares), Amansa Holdings (4.63 Lakh shares), Invesco Mutual Fund (3.54 Lakh shares), SBI Mutual Fund (5.25 Lakh shares), Monetary Authority of Singapore (2.37 Lakh shares), T Rowe Price International Discovery Fund (2.32 Lakh shares). 

This is the second instance when these investors have lightened their holding in SEDEMAC after paring stake via its initial public offering (IPO) earlier this year. The IPO comprised solely of an offer for sale (OFS) component and saw SEDEMAC’s investors offload 80.43 Lakh shares, netting a cumulative ₹1,087 Cr from the issue.

Investors like Xponentia Capital Partners, Mace, IIT-Bombay’s SINE, 360 One, HDFC Life Insurance, among others, were some of the selling shareholders in the IPO. 2X return on investment.



Source link
Related Topics:Tech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.